| RS1158166019 |
RERE
|
Health Risk |
Pathogenic |
— |
| RS1158166238 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1158167906 |
PLOD3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS1158171614 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS115817750 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1158185476 |
RSPH3
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 32, Primary ciliary dyskinesia 32 |
| RS115818625 |
POMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Autosomal recessive limb-girdle muscular dystrophy type 2K |
| RS11581921 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis Imperfecta |
| RS1158193880 |
PHKA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS1158194122 |
PDHX
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-alpha deficiency |
| RS11581962 |
TOR1AIP1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS115819851 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1158206003 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1158231145 |
EYS
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1158240863 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 20, Leber congenital amaurosis 2 |
| RS115825044 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1158254994 |
HOXA13
|
Health Risk |
Pathogenic |
Hand-foot-genital syndrome, Hand-foot-genital syndrome |
| RS115826080 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Diabetes mellitus, transient neonatal |
| RS1158267419 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1158268529 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS1158274146 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS1158289237 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 4 |
| RS1158292126 |
POU3F3
|
Health Risk |
Pathogenic/Likely pathogenic |
Snijders blok-fisher syndrome, Snijders blok-fisher syndrome |
| RS1158294764 |
PAX1
|
Health Risk |
Pathogenic |
Otofaciocervical syndrome 2, Otofaciocervical syndrome 2 |
| RS1158295938 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1158299404 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS115830086 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS115831287 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS1158318107 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1158333072 |
PKP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 9, Cardiovascular phenotype |
| RS115833794 |
NID2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115834468 |
DNAJC21
|
Health Risk |
Conflicting classifications of pathogenicity |
DNAJC21-related disorder, DNAJC21-related disorder |
| RS1158349299 |
CC2D2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Joubert syndrome |
| RS1158350974 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
COL4A4-related disorder, Autosomal recessive Alport syndrome |
| RS115835484 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS1158357314 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS115836330 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral arteriopathy, autosomal dominant |
| RS1158367720 |
AP5Z1
|
Health Risk |
Likely pathogenic |
— |
| RS1158375704 |
TMPRSS15
|
Health Risk |
Pathogenic |
— |
| RS115839474 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS115840214 |
PITRM1
|
Health Risk |
Conflicting classifications of pathogenicity |
PITRM1-related disorder, PITRM1-related disorder |
| RS1158418673 |
CDKL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 2 |
| RS1158449736 |
TCIRG1
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS115845031 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS1158454977 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1158456786 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1158457053 |
ACADM
|
Health Risk |
Pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS115849119 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS115849497 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS115850223 |
CCDC40
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 15 |
| RS115851096 |
CD3G
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to CD3gamma deficiency, Combined immunodeficiency due to CD3gamma deficiency |
| RS115853053 |
CFAP418
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 16 |
| RS1158534509 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS1158538758 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1158542233 |
PKDCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhizomelic limb shortening with dysmorphic features, Rhizomelic limb shortening with dysmorphic features |
| RS1158542687 |
RECQL
|
Health Risk |
Conflicting classifications of pathogenicity |
RECON progeroid syndrome, RECON progeroid syndrome |
| RS1158550690 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 2, Cardiovascular phenotype |
| RS115855236 |
SREBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1158562606 |
TMPRSS3
|
Health Risk |
Likely pathogenic |
— |
| RS115857633 |
SAG
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Oguchi disease |
| RS1158582797 |
ERCC6
|
Health Risk |
Pathogenic |
— |
| RS1158594747 |
WNT7B
|
Health Risk |
Pathogenic |
Matthew-Wood syndrome, Matthew-Wood syndrome |
| RS115859827 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS115859828 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, SETD2-related disorder |
| RS115863049 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS11586344 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Adult hypophosphatasia |
| RS115865111 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1158662109 |
POLR3B
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |
| RS115866745 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, SLX4-related disorder |
| RS1158674229 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS1158674912 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS115867512 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS115869593 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1158713034 |
EYS
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1158714606 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1158725219 |
BRAF
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, RASopathy |
| RS1158728649 |
SLX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1158730024 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1158736298 |
MECP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe neonatal-onset encephalopathy with microcephaly, MECP2-related disorder |
| RS1158737546 |
D2HGDH
|
Health Risk |
Pathogenic |
D-2-hydroxyglutaric aciduria 1, D-2-hydroxyglutaric aciduria 1 |
| RS1158743738 |
SKIC3
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS1158745675 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS115874872 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1158755002 |
SPTB
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS115875661 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1158759883 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Fumarase deficiency |
| RS1158763615 |
TRIO
|
Health Risk |
Likely pathogenic |
— |
| RS115876786 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1158768165 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS1158771233 |
NALCN
|
Health Risk |
Pathogenic |
Hypotonia, infantile |
| RS115877658 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Inborn genetic diseases |
| RS115877891 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS115877951 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Hereditary spastic paraplegia 30 |
| RS115881121 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1158822302 |
PORCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115882574 |
NOBOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Premature ovarian failure 5, Inborn genetic diseases |
| RS115882953 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Inborn genetic diseases |
| RS115883468 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS1158843179 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1158854454 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular cardiomyopathy, Hypertrophic cardiomyopathy 14 |